Skip to content
Abivax
EN
FR
About Abivax
Our Mission
Company History
Our Leadership
Contact Us
Our Science
Novel MOA
Obefazimod
Our Research
Our Pipeline
Publications
Investors
Overview
Press Releases
News
Share Price
Investor Documents
General Meeting
Corporate Presentation
EN
FR
News & Events
Press Coverage
2023
2022
2021
2020
2019
Les Echos Investir
August 19, 2021
Nouvelle étape pour Abivax au Japon
4investors
August 18, 2021
Abivax: Grünes Licht in Japan für ABX464-Studie
Rheumatology Network
July 7, 2021
Claire Daien, MD: ABX464 Treatment for Rheumatoid Arthritis
Biotech Finances
June 25, 2021
L’essentiel de la semaine du 21 au 25 juin 2021
BioSpace
June 24, 2021
Global Roundup June 24
1
2
3
…
7
